Department of Surgical Oncology, The Netherlands, Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX, Amsterdam, The Netherlands.
Department of Medical Oncology, The Netherlands, Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX, Amsterdam, The Netherlands.
BMC Cancer. 2022 Sep 26;22(1):1018. doi: 10.1186/s12885-022-10069-6.
Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between BC and TC in the Netherlands.
This is a retrospective cohort study during the period of 1989-2020 retrieved from the Netherlands Cancer Registry (NCR). Patients diagnosed with BC-TC and BC alone as control group and TC-BC and TC alone as control group were included. The primary outcome was the standardized incidence ratio (SIR) of BC-TC and TC-BC. Secondary outcomes included data on the demographics, type of malignancy, treatment and overall survival (OS).
The incidence of TC among 318.002 women with BC (BC-TC) was 0.1% (423 patients) (SIR = 1.86 (95% CI: 1.40-2.32)) and the incidence of BC among 12,370 patients with TC (TC-BC) was 2.9% (355 patients) (SIR = 1.46 (95% CI: 1.09-1.83)). BC-TC patients were younger compared to the BC alone group at BC diagnosis (55 vs 60 years, p < 0.001). The age-adjusted odds ratio to develop TC was not significantly increased for patients who received chemotherapy and radiotherapy. Most TC cases were synchronous tumors after BC diagnosis (19%) with a TNM stage 1. Only 6% of the BC tumors after TC occurred synchronous with a TNM stage 1 in most cases. The OS of all groups was the most favorable in patients with both BC and TC compared to BC- and TC alone.
The SIR of TC after BC diagnosis and BC after TC diagnosis was higher than predicted based on the rates of the general population. TC and BC as second primary tumors were diagnosed in an early stage and did not affect overall survival. Therefore, Dutch women who have been treated for BC or TC require no special surveillance for their thyroid- and breast gland.
乳腺癌(BC)和分化型甲状腺癌(TC)是两种最常见的女性高发癌症类型。BC 和 TC 可同时或异时发生,两者的发生率均高于预期。本研究旨在探讨荷兰 BC 和 TC 之间的关联。
这是一项回顾性队列研究,数据来源于 1989-2020 年荷兰癌症登记处(NCR)。纳入同时诊断为 BC-TC 和 BC 作为对照组、TC-BC 和 TC 作为对照组的患者。主要结局是 BC-TC 和 TC-BC 的标准化发病比(SIR)。次要结局包括人口统计学、恶性肿瘤类型、治疗和总生存(OS)数据。
318002 例 BC 患者(BC-TC)中 TC 的发病率为 0.1%(423 例)(SIR=1.86(95%CI:1.40-2.32)),12370 例 TC 患者(TC-BC)中 BC 的发病率为 2.9%(355 例)(SIR=1.46(95%CI:1.09-1.83))。与单独诊断为 BC 的患者相比,BC-TC 患者在诊断 BC 时更年轻(55 岁比 60 岁,p<0.001)。接受化疗和放疗的患者发生 TC 的年龄调整比值比无显著增加。大多数 TC 病例是在诊断 BC 后同步发生的(19%),且 TNM 分期为 1 期。在大多数情况下,TC 后发生的 BC 肿瘤中只有 6%与 TNM 分期 1 同步发生。与单独诊断为 BC 和 TC 的患者相比,所有组的 OS 均在同时诊断为 BC 和 TC 的患者中最有利。
诊断为 BC 后和诊断为 TC 后 TC 的 SIR 高于基于一般人群的发病率。作为第二原发肿瘤的 TC 和 BC 在早期被诊断出来,并未影响整体生存。因此,荷兰女性在接受 BC 或 TC 治疗后无需对其甲状腺和乳腺进行特殊监测。